Refine
Has Fulltext
- yes (21)
Is part of the Bibliography
- yes (21)
Year of publication
Document Type
- Journal article (20)
- Doctoral Thesis (1)
Keywords
- melanoma (8)
- Merkel cell carcinoma (7)
- polyomavirus (4)
- large T antigen (2)
- peptide vaccination (2)
- therapy (2)
- A375 (1)
- CD274 (1)
- CD30 (1)
- CRISPR (1)
- Cutaneous lymphoma (1)
- DNA repair (1)
- Epigenetic regulation (1)
- FoxO3 (1)
- GSK3 (1)
- HDAC (1)
- Hautkrebs (1)
- Hippo signaling (1)
- Histone deacetylase (1)
- Immunoconjugate (1)
- JAK2 (1)
- Krebs <Medizin> (1)
- LSD1 (1)
- Large T antigen (1)
- Lysine-specific methylase (1)
- MCC (1)
- MHC class I chain-related protein (1)
- Melanom (1)
- Melanoma (1)
- Merkel cell polyomavirus (1)
- PD-L1 (1)
- PIK3CA mutations (1)
- Priming (1)
- STAT3 (1)
- T antigen (1)
- T-Lymphozyt (1)
- T-Zelle (1)
- T-antigen (1)
- T-cell (1)
- T-cell reactivity (1)
- TP53 (1)
- TRRAP (1)
- Tubulin (1)
- XPA (1)
- akt (1)
- antagomiRs (1)
- antibody–drug conjugates (1)
- apoptosis (1)
- artesunate (1)
- cancer (1)
- cancer treatment (1)
- cell cycle (1)
- cell staining (1)
- cultured fibroplasts (1)
- cutaneous T-cell lymphoma and Merkel cell carcinoma (1)
- cutaneous T-cell-lymphoma (1)
- epigenetic silencing (1)
- expression (1)
- ferroptosis (1)
- focal adhesion (1)
- glycogen synthase kinase 3 (1)
- heat shock response (1)
- immune suppression (1)
- immunoconjugate (1)
- interferon (1)
- knockout (1)
- large cell transformation (1)
- membrans proteins (1)
- miR-375 (1)
- mycosis fungoides (1)
- nucleotide excision repair (1)
- oncodermatology (1)
- p53 (1)
- panel sequencing (1)
- phthalazinone pyrazole (1)
- polymavirus (1)
- polymerase chain reaction (1)
- predictive marker (1)
- priming (1)
- protein variant (1)
- rare (1)
- regulatory T cell (1)
- retinoblastoma protein (1)
- single nucleotide polymorphism (1)
- skin cancer (1)
- skin squamous cell carcinoma (1)
- squamous cell (1)
- survivin (1)
- survivin T-cell reactivity (1)
- tertiary lymphoid tissue (1)
- tertiäres lymphatisches Gewebe (1)
- transcription factors (1)
- tumor-draining lymph node (1)
- tumors (1)
- viral carcinogenesis (1)
Institute
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (21)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Comprehensive Cancer Center Mainfranken (1)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (1)
- Medizinische Klinik und Poliklinik II (1)
- Pathologisches Institut (1)
- Rudolf-Virchow-Zentrum (1)
EU-Project number / Contract (GA) number
- 277775 (2)
Merkel cell carcinoma (MCC) is frequently caused by the Merkel cell polyomavirus (MCPyV), and MCPyV-positive tumor cells depend on expression of the virus-encoded T antigens (TA). Here, we identify 4-[(5-methyl-1H-pyrazol-3-yl)amino]-2H-phenyl-1-phthalazinone (PHT) — a reported inhibitor of Aurora kinase A — as a compound inhibiting growth of MCC cells by repressing noncoding control region (NCCR)-controlled TA transcription. Surprisingly, we find that TA repression is not caused by inhibition of Aurora kinase A. However, we demonstrate that β-catenin — a transcription factor repressed by active glycogen synthase kinase 3 (GSK3) — is activated by PHT, suggesting that PHT bears a hitherto unreported inhibitory activity against GSK3, a kinase known to function in promoting TA transcription. Indeed, applying an in vitro kinase assay, we demonstrate that PHT directly targets GSK3. Finally, we demonstrate that PHT exhibits in vivo antitumor activity in an MCC xenograft mouse model, suggesting a potential use in future therapeutic settings for MCC.